Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- | JP | Pharmacopoeia | Reference Standards| PharmaCompass.com

Please Wait

Applying Filters...

Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 7 USDMF, 7 CEP/COS, 1 JDMF, 3 EU WC, 2 NDC API, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 30 FDA Orange Book, 2 Europe, 4 Canada, 8 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL, INJECTABLE;INJECTION - EQ 250MG BASE/VIAL, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

2 Topical, 1 Parenteral, 1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

11 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 JP

2 JP

$ Xls

Filters

Filters

FILTER :

filter Reference Standard Reset all filters

2 All

01 2Hydrocortisone Succinate

filter Monograph in Japanese Pharmacopoeia Reset all filters

Product Main Page

01

Japanese Pharmacopoeia

Japan

The Pharmacy Technology

Not Confirmed

02

Japanese Pharmacopoeia

Japan

The Pharmacy Technology

Not Confirmed

Contact us
to update this info